World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0000647283
Reproduction Date:

Title: Lidocaine/prilocaine  
Author: World Heritage Encyclopedia
Language: English
Subject: Prilocaine, Local anesthetic, Local anesthetics, Iontocaine, Mepivacaine
Collection: Combination Drugs, Local Anesthetics
Publisher: World Heritage Encyclopedia


Combination of
Lidocaine anesthetic
Prilocaine anesthetic
CAS Registry Number  Y
PubChem CID:
ChemSpider  Y

Lidocaine/prilocaine is a eutectic mixture of equal quantities (by weight) of lidocaine and prilocaine. A 5% emulsion preparation, containing 2.5% each of lidocaine/prilocaine, is marketed by APP Pharmaceuticals under the trade name EMLA (an abbreviation for Eutectic Mixture of Local Anesthetics).[1]


  • Eutectic mixture 1
  • Clinical use 2
    • Indications 2.1
    • Dosage forms 2.2
    • Circumcision 2.3
  • Compendial status 3
  • See also 4
  • References 5
  • External links 6

Eutectic mixture

Separately, lidocaine and prilocaine are solid bases. When mixed in equal quantities by weight, however, they form a eutectic mixture – that is the melting point of the mixture is lower than the melting points of the individual components. The lidocaine/prilocaine eutectic mixture is an oil with a melting point of 18°C, thus can be formulated into preparations without the use of a non-aqueous solvent.[2] This allows higher concentrations of anaesthetic to be formulated into the preparation and maintained during application.

Clinical use


The lidocaine/prilocaine combination is indicated for dermal anaesthesia. Specifically it is applied to prevent pain associated with intravenous catheter insertion, blood sampling, superficial surgical procedures; and topical anaesthesia of leg ulcers for cleansing or debridement.[3] Also, it can be used to numb the skin before tattooing as well as electrolysis and laser hair removal. It is also sometimes used in advance of injected local anaesthetics for minor surgery and biopsies.

A topical spray consisting of an aerosol formulation of lidocaine and prilocaine was evaluated under the name PSD502 for use in treating premature ejaculation. The spray is applied on the penile skin prior to intercourse. While this formulation was not approved by the FDA,[4] a similar product, Promescent, is available over-the-counter in the U.S.

Dosage forms

Lidocaine/prilocaine eutectic mixture is marketed as a 5% oil-in-water emulsion incorporated in a cream base (EMLA cream) or a cellulose disk (EMLA patch). The cream is applied under an occlusive dressing, while the patch incorporates an occlusive dressing to facilitate absorption of lidocaine and prilocaine into the area where anaesthesia is required. Local dermal anaesthesia is achieved after approximately 60 minutes, whereupon the occlusive dressing (or patch) is removed. The duration of anaesthesia is approximately two hours following removal of the occlusive dressing.

It is important to note that E. Fougera & Co., makers of the generic cream widely used in the United States as Lidocaine and Prilocaine Cream, 2.5%/2.5%, recommends different timing for application of the cream as well as length of anesthesia. They state the cream must be applied at least one hour before the start of a routine procedure and for two hours before the start of a painful procedure. Additionally, they state that the duration of effective skin anesthesia will be at least one hour after removal of the occlusive dressing.[5]


Lidocaine/prilocaine eutectic mixture is used during circumcision in newborn boys and is considered efficacious and safe for the prevention of pain from circumcision.[6][7]

Compendial status

See also


  1. ^ "Topical Anesthesia Use in Children: Eutectic Mixture of Local Anesthetics". Retrieved 2014-01-07. 
  2. ^ "EMLA Official FDA information, side effects and uses". Retrieved 2014-01-07. 
  3. ^ Heinen et al 2003
  4. ^ "PSD502 TEMPE Spray". Retrieved 4 July 2014. 
  5. ^ Lidocaine and Prilocaine Cream, 2.5%/2.5%, package insert. E. Fougera & Co. package insert. Melville, New York, 9/2007.
  6. ^ Taddio, A; Ohlsson, K; Ohlsson, A (2000). Ohlsson, Arne, ed. "Lidocaine-prilocaine cream for analgesia during circumcision in newborn boys". The Cochrane database of systematic reviews (2): CD000496.  
  7. ^ Taddio, A; Stevens, B; Craig, K; Rastogi, P; Ben-David, S; Shennan, A; Mulligan, P; Koren, G (1997). "Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision". The New England Journal of Medicine 336 (17): 1197–201.  
  8. ^ The United States Pharmacopeial Convention. "Revision Bulletin: Lidocaine and Prilocaine Cream–Revision to Related Compounds Test". Retrieved 10 July 2009. 

External links

  • Emla english Information
  • Emla Product Information
  • AstraZeneca product information
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.